Trials / Unknown
UnknownNCT04772443
Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507
A Randomized, Double-blind, Multi-center, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 280 (estimated)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the efficacy and safety of DWJ1506 and DWJ1507 in the patients with dyslipidemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWJ1506 | DWJ1506 |
| DRUG | DWJ1507 | DWJ1507 |
| DRUG | DWC202011 | DWC202011 |
| DRUG | DWJ1177 | DWC202011 |
Timeline
- Start date
- 2021-02-01
- Primary completion
- 2022-12-01
- Completion
- 2022-12-01
- First posted
- 2021-02-26
- Last updated
- 2021-02-26
Source: ClinicalTrials.gov record NCT04772443. Inclusion in this directory is not an endorsement.